| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |